Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD (L)-1 therapy: an open-label, ...

Direct, morphological comparisons between human and animal cells could boost the findings, says Paredes.

A new, label-free method for identifying senescent cells has been developed, offering a more convenient tool for research into ageing.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.

Checkup wants to hear your experiences with cellphone bans in schools. Plus, what was your unexpected encounter with a wild animal?

Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...